RYAN vs. MFC, SLF, WTW, PUK, PFG, CRBG, EQH, EG, AEG, and KNSL
Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Manulife Financial (MFC), Sun Life Financial (SLF), Willis Towers Watson Public (WTW), Prudential (PUK), Principal Financial Group (PFG), Corebridge Financial (CRBG), Equitable (EQH), Everest Group (EG), Aegon (AEG), and Kinsale Capital Group (KNSL). These companies are all part of the "insurance" industry.
Ryan Specialty vs.
Ryan Specialty (NYSE:RYAN) and Manulife Financial (NYSE:MFC) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.
Ryan Specialty presently has a consensus price target of $74.40, suggesting a potential upside of 17.60%. Manulife Financial has a consensus price target of $37.50, suggesting a potential upside of 22.85%. Given Manulife Financial's stronger consensus rating and higher probable upside, analysts plainly believe Manulife Financial is more favorable than Ryan Specialty.
Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.7%. Manulife Financial pays an annual dividend of $1.23 per share and has a dividend yield of 4.0%. Ryan Specialty pays out 57.1% of its earnings in the form of a dividend. Manulife Financial pays out 59.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Manulife Financial has raised its dividend for 11 consecutive years. Manulife Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Manulife Financial received 425 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 67.95% of users gave Manulife Financial an outperform vote while only 41.25% of users gave Ryan Specialty an outperform vote.
84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 52.6% of Manulife Financial shares are owned by institutional investors. 11.1% of Ryan Specialty shares are owned by insiders. Comparatively, 0.0% of Manulife Financial shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Ryan Specialty and Ryan Specialty both had 11 articles in the media. Manulife Financial's average media sentiment score of 0.96 beat Ryan Specialty's score of 0.35 indicating that Manulife Financial is being referred to more favorably in the news media.
Ryan Specialty has a net margin of 10.31% compared to Manulife Financial's net margin of 9.79%. Ryan Specialty's return on equity of 47.90% beat Manulife Financial's return on equity.
Manulife Financial has higher revenue and earnings than Ryan Specialty. Manulife Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Ryan Specialty has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Manulife Financial has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.
Summary
Manulife Financial beats Ryan Specialty on 12 of the 21 factors compared between the two stocks.
Get Ryan Specialty News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ryan Specialty Competitors List
Related Companies and Tools
This page (NYSE:RYAN) was last updated on 1/25/2025 by MarketBeat.com Staff
